التفاصيل البيبلوغرافية
العنوان: |
Efficacy of Artificial Pancreas Use in Patients With Type 2 Diabetes Using Intensive Insulin Therapy: A Randomized Crossover Pilot Trial. |
المؤلفون: |
Taleb, Nadine, Carpentier, André C., Messier, Virginie, Ladouceur, Martin, Haidar, Ahmad, Rabasa-Lhoret, Rémi |
المصدر: |
Diabetes Care; Jul2019, Vol. 42 Issue 7, pe107-e109, 3p |
مصطلحات موضوعية: |
ARTIFICIAL pancreases, TYPE 2 diabetes, CROSSOVER trials, INSULIN, TYPE 1 diabetes, INSULIN derivatives, GLUCAGON-like peptides, EMPAGLIFLOZIN |
مستخلص: |
The article discusses a study on the efficacy of artificial pancreas (AP) in type 2 diabetes (T2D) patients using intensive insulin therapy. Results showed the applicability of AP in a controlled setting for T2D patients on intensive insulin, and the possible translation of improved glucose control into improved time for targeting a range of complications. Also noted is the need to weigh the technology's benefits against the costs and complexity of AP systems. |
قاعدة البيانات: |
Complementary Index |